Merck MS Drug Fails to Meet Target of Late-Stage Trials

[ad_1] Merck’s multiple sclerosis drug evobrutinib didn’t meet a key goal in late-stage trials. The German pharmaceutical company’s phase 3 clinical trials for the drug did not achieve their primary…

Bayer Shares Tumble After Clinical Trial Failure, Loss in Roundup Case

[ad_1] Updated Nov. 20, 2023 3:16 pm ET Bayer shares fell sharply after the company stopped a late-stage study for a blood-thinning drug early because of lack of efficacy and…

WSJ News Exclusive | The Next Hot Obesity Drug Won’t Be Approved for Years. Online Sellers Hawk It Anyway.

[ad_1] Eli Lilly’s retatrutide will be in clinical trials for the next three years, but knockoff versions already abound. [ad_2] Source link

Opinion | Proper Nutrition Can Prevent Postpartum Depression

[ad_1] The new drug is a breakthrough, but taking calcium during pregnancy may minimize the need for it. [ad_2] Source link

Doctors Transplanted a Pig Kidney Into a Person a Month Ago. It’s Still Working.

[ad_1] A genetically modified pig kidney transplanted into a brain-dead person has worked for 32 days and counting, advancing efforts to use animals to ease perennial shortages for humans. [ad_2]…

The Obesity Drug Revolution Just Got Real

[ad_1] New data show Novo Nordisk’s Wegovy reduces risk of heart attack and stroke, paving the way for greater insurance coverage. [ad_2] Source link

First Pill for Postpartum Depression Is Approved by FDA

[ad_1] The first pill to treat post-pregnancy depression will soon be available, after the Food and Drug Administration approved it. [ad_2] Source link

Moderna, Merck Show Progress Toward Cancer Vaccines

[ad_1] An mRNA shot helped prevent relapse in high-risk melanoma patients. [ad_2] Source link

Regeneron and Sanofi Look for Billions From COPD Drug

[ad_1] The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. [ad_2] Source link

Pfizer Bids Adieu to Covid Boom Years

[ad_1] Markets Heard on the Street Financial bonanza from Covid-19 is fading, putting pressure on management to deliver new avenues of growth [ad_2] Source link